|
Market Closed -
Toronto S.E.
15:40:12 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 29.56 CAD | +1.97% |
|
+5.76% | +16.88% |
| 08-19 | Gilead Sciences Insider Sold Shares Worth $3,853,908, According to a Recent SEC Filing | MT |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +1.97% | +5.76% | +16.88% | +23.42% | - | 181B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GILD Stock
- GILD Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
